Cel­gene shares jump as Bris­tol-My­ers gains key sup­port from proxy ad­vis­er for loom­ing buy­out vote

Bris­tol-My­ers Squibb $BMY ex­ecs have won a pair of im­por­tant en­dorse­ments for its big Cel­gene buy­out.

In­sti­tu­tion­al Share­hold­er Ser­vices, a share­hold­er ad­vis­er that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER